Background {#Sec1}
==========

Population aging is seen worldwide. Thus, it is important that an appropriate quality of life (QOL) is maintained for the entire lifespan of any individual. Adult spinal deformity (ASD) can affect the sagittal alignment of the spine, which may impact the QOL \[[@CR1]--[@CR3]\]. The ultimate aim of ASD treatment, even in younger patients, is to ensure that patients are ambulant without requiring a cane or handrail for support. ASD affects muscular strength leading to changes in the range of motion of the trunk, lower extremities, and the whole body \[[@CR4], [@CR5]\].

Individuals with ASD will receive lower scores in all domains of the 36-Item Short Form Survey as they age, while in other chronic conditions such a decline with age is not observed \[[@CR6]\]. For evaluating ASD, ideal values for parameters including pelvic incidence-lumbar lordosis (PI-LL), pelvic tilt (PT), and sagittal vertical axis (SVA) were proposed by the International Spine Study Group \[[@CR3]\], and target values have been modified to include age and surgical results \[[@CR7]--[@CR9]\].

Height loss is an age-related physical change that occurs in all individuals over 50 years and that elderly people are aware of \[[@CR10]\], and is correlated with osteoporosis \[[@CR11], [@CR12]\], vertebral fracture \[[@CR13]--[@CR16]\], and mortality \[[@CR17]\]. Decreased QOL is also reportedly associated with height loss according to the EQ-5D scores \[[@CR18]\].

Although both ASD and height loss are associated with aging, no study has examined the relationship between height loss and ASD, based on the abovementioned parameters. Besides, many epidemiological studies were conducted on height loss worldwide; however, over the 30 years longitudinal no epidemiological studies have been conducted in this field. The purpose of this 34-year longitudinal cohort study was to investigate the relationship between ASD and height loss in community-based volunteers and to determine the effects of sex.

Methods {#Sec2}
=======

Cohort selection {#Sec3}
----------------

This study is a follow-up of an epidemiological study by Takemitsu et al. in 1983, in Furano, Hokkaido, Japan \[[@CR19]\]. Of the 249 adult volunteers who lived locally, and who had participated in the original study in 1983, we included 53 volunteers (32 men/21 women) in 2017 for this follow-up 34-year longitudinal study. The subjects were living in an agriculture area and trunk bending positions were a requirement of their job. The initial recruitment of the cohort was done by sending invitations to all rural residents of the area using the information in a resident ledger. In the current study, those who had participated in the initial study were contacted by phone and invited to take part in this survey.

The inclusion criteria were as follows: no spinal or major joint surgery between 1983 and 2017, ability to walk independently to our hospital for the present study, and aged less than 55 years in 1983 in consideration of current age.

The exclusion criteria were being unable to stand in the correct posture during radiography, unable to tolerate the pain, osteoporosis fracture, paralysis of trunk or lower extremity, and not consenting to the study. Figure [1](#Fig1){ref-type="fig"} presents the subject details. Fig. 1Flowchart of the enrolment process in our study. We approached 104 local subjects, of which 53 agreed to participate in this study

Spinal X-ray {#Sec4}
------------

The subjects underwent radiography of the entire spine in an upright position in 1983 and 2017. The participants were instructed to stand in a relaxed position and look straight ahead, with their fists at the level of the clavicle.

The heights of all subjects were measured in meters without their shoes, with the back of their head, buttocks, back, and heels against an upright board. The back muscle was stretched as much as possible, and feet were supinated by about 30°. Participants with height loss were then selected and divided into two groups: those with ≤4 cm (small height less, S group) and those with \> 4 cm (large height loss, L group) loss of height.

Radiographic parameters {#Sec5}
-----------------------

Standardized radiographic measurements of sagittal spino-pelvic parameters included thoracic kyphosis (TK), lumbar lordosis (LL), PT, pelvic incidence (PI), sacral slope (SS), and SVA \[[@CR20], [@CR21]\] (Fig. [2](#Fig2){ref-type="fig"}). ASD was radiologically evaluated based on the SRS-Schwab ASD classification sagittal modifiers \[[@CR3]\]. Degenerative spondylosis (DS) was determined as 5% percent slip \[[@CR22]\] and degenerative lumbar scoliosis (DLS) was identified based on the Cobb method \[[@CR23]\] with a scoliotic angle of more than 10° \[[@CR24]--[@CR26]\]. Fig. 2Radiographic measurements of spinopelvic alignment. Left: thoracic kyphosis (TK), lumbar lordosis (LL), sagittal vertical axis (SVA). Right: pelvic incidence (PI), sacral slope (SS), and pelvic tilt (PT)

Statistical analysis {#Sec6}
--------------------

All statistical analyses were performed using SPSS Statistics version 12 (IBM, Tokyo, Japan). All data are expressed as mean and range. Variables that were normally distributed were analyzed using the Shapiro-Wilk test. When measured variables were found to have a non-normal distribution, Spearman's correlation was used to evaluate the association between height loss and spino-pelvic parameters. Sub-analyses were performed to evaluate the association between height loss and sex, DS, and DLS.

In comparing the height loss between the 2 groups, if lack of normality was rejected, a t-test was performed. If the lack of normality was significant, the Wilcoxon signed rank test or Mann-Whitney U-test was performed, as appropriate. A *P-*value of \< 0.05 was considered statistically significant.

Results {#Sec7}
=======

The mean age of the subjects was 44.4 (31--55) years at baseline and 78.6(65--89) years at the final follow-up. The mean follow-up period was 34.2 (34--34.4) years. The mean height of the subjects was 157.4 (140--170) cm at baseline and 153.6(132--169) cm at the final follow-up, with a mean height loss of 3.8 cm over 34 years.

A summary of longitudinal changes in radiographic variables from baseline to the final follow-up is presented in Table [1](#Tab1){ref-type="table"}. Statistical analyses revealed significant longitudinal changes in all parameters except for body mass index and TK. Table 1Changes in characteristics of participants after 34 years^1^VariablesBaselineFinal follow-up***P*** value^**2**^Age (years)44.4 (31 to 55)78.6 (65 to 89)\< 0.0001Height (cm)157.4 (140 to 170)153.6 (132 to 169)\< 0.0001Body weight (kg)61.9 (44 to 85)58.0 (38 to 87)\< 0.0001BMI (kg/m^2^)24.9 (20 to 31)24.4 (18 to 30)0.203TK35.4 (16 to 66)34.3 (2 to 69)0.515LL55.1 (32 to 79)32.4 (−32 to 77)\< 0.0001PT14.4 (0 to 39)25.9 (4 to 54)\< 0.0001PI56.0 (33 to 76)54.4 (27 to 78)0.015PI-LL0.9 (− 25 to 30)21.1 (−15 to 84)\< 0.0001SS41.4 (26 to 58)28.7 (0 to 48)\< 0.0001SVA4.3 (−40 to 67)63.9 (−31 to 282)\< 0.0001^1^Data are presented as mean (range)^2^*P* value \< 0.05 was considered significantAbbreviations: *BMI* body mass index, *TK* thoracic kyphosis, *LL* lumbar lordosis, *PT* pelvic tilt, *PI* pelvic incidence, *SS* sacral slope, *SVA* sagittal vertical axis

Spino-pelvic parameters including PI-LL, PT, and SVA were significantly associated with height loss in both male and female subjects (Table [2](#Tab2){ref-type="table"}). Based on our definition for DS, 7 participants were in the DS(+) group and 46 participants in the DS(−) group. Upon assessing for DLS, 26 participants were in the DLS(+) group and 27 in the DLS(−) group. The large height loss group had more patients with DLS, but there were no significant differences in height loss between the DS groups (Tables [3](#Tab3){ref-type="table"}, [4](#Tab4){ref-type="table"}). When we compared height loss in terms of sex, 31% of the participants in the large height loss group were men and 76% were women, suggesting that female subjects had greater height loss than male subjects (Table [5](#Tab5){ref-type="table"}). Table 2Spearman's correlations among different parameters in male and female participantsVariablesMaleFemaleCorrelation coefficient***P*** value^1^Correlation coefficient***P*** value^1^Weight0.4380.0120.1870.427BMI0.3020.0930.1360.567TK−0.0580.752−0.2440.300LL0.4380.0140.5300.016PT0.3740.0350.5400.014PI0.1650.3660.060.801PI-LL0.4600.0080.5530.012SS−0.4320.014−0.6350.003SVA0.5350.0020.5270.017^1^*P* value \< 0.05 was considered significantAbbreviations: *BMI* body mass index, *TK* thoracic kyphosis, *LL* lumbar lordosis, *PT* pelvic tilt, *PI* pelvic incidence *SS* sacral slope, *SVA* sagittal vertical axisTable 3Comparison between degenerative spondylosis and height lossL group (\> 4 cm) \[***N*** = 26\]S group (≤4 cm) \[***N*** = 27\]TotalDS (+)257DS (−)242246Total262753*P-*value = 0.226 using a χ^2^ -test.*DS* degenerative spondylosis.Table 4Comparison between degenerative lumbar scoliosis and height lossL group (\> 4 cm) \[***N*** = 26\]S group (≤4 cm) \[***N*** = 27\]TotalDLS (+)17926DLS (−)91827Total262753*P-*value = 0.02 using a χ^2^ -test.*DLS* degenerative lumbar scoliosis.Table 5Comparison of height loss between the sexesL group (\> 4 cm) \[***N*** = 26\]S group (≤4 cm) \[***N*** = 27\]TotalMale (%)10 (31%)22 (69%)32Female (%)16 (76%)5 (24%)21Total262753*P* value =0.001 using a χ^2^ -test.

Discussion {#Sec8}
==========

To the best of our knowledge, this 34-year longitudinal cohort study is the first to examine the relationship between ASD and height loss. We observed that height loss was significantly correlated with changes in the sagittal modifiers of the SRS-Schwab classification \[[@CR3]\]. Our results showed that height loss was more common in female subjects and was related to coronal and sagittal deformities observed in DLS and ASD.

There was no significant change in the values for TK over 34 years, which is similar to the findings of Kobayashi et al. who also reported small changes in TK over their study period of 12.3 years \[[@CR4]\]. On the other hand, Diebo et al. reported a wider range for TK, with spinal malalignment ranging from hyper- to hypokyphosis \[[@CR27]\], which might have been because of the wide range of spine flexibility, disc degenerations, and age observed in their cohort. Kamimura also showed that spinal kyphosis was significantly associated with height loss in elderly Japanese women \[[@CR28]\]. Their report used self-reported categories of kyphosis, which though simple, was not objective.

Aging-related spinal changes begin with degenerative inter-vertebral disk changes \[[@CR29]\]. Later, height loss may occur because of several causes, such as progression of intervertebral disk degeneration, vertebral deformity or fracture, and decreased muscle strength, all of which are found in subjects with ASD. Hence, radiographic parameters are useful tools for subjective evaluation of ASD, since changes in SVA, PT, and PI-LL might also lead to height loss.

The main cause for DLS is disc degeneration, leading to decreased disc height and the progression of DLS. Faraj et al. provided strong evidence that increased disc degeneration in DLS, the first sign of height loss, leads to progression of the lumbar scoliosis curve \[[@CR30]\]. In the current study, more subjects were diagnosed with DLS compared to the general population. Such a high incidence might be due to the fact that most people living in this area are agricultural workers in the area, and the inherent requirement of the job is that they should remain in a forward bending position for long periods of time. This position increases the load on the lumbar spine, which can be a cause for the higher prevalence of degenerative scoliosis in this cohort.

Furthermore, it is reported that LL decreases and SVA increases as degenerative scoliosis progresses \[[@CR31]\], with preceding coronal and sagittal deformities also influencing each other \[[@CR29]\]. Hence, scoliosis is reportedly one of the factors associated with height loss of 3 cm or more \[[@CR11]\].

In our study, height loss was more pronounced in women, which might be because of the differences in the skeletal structure between the sexes. It should be noted that these differences may be observed over time; however, to date, no prospective studies have confirmed this change, although Takemitsu et al. have reported a higher prevalence of lumbar degenerative kyphosis in women in a previous study \[[@CR19]\], which might explain the higher prevalence of height loss in women than in men. Besides, women are reportedly more likely to experience degenerative disk changes \[[@CR32]\]. Furthermore, while vertebral deformity is expected to occur in elderly subjects \[[@CR32]\], women were at a higher risk of vertebral fractures associated with aging. Reduced muscular strength due to advanced age and vertebral fractures because of osteoporosis mainly occur in women, and the female sex is a risk factor for DLS \[[@CR33]\]. Therefore, ASD and height loss are more commonly seen in women. In a 10-year prospective study, Yoshimura reported that in men, height loss did not differ significantly between those in the 40--49 years age group and the 70--79 years age group, but in women, height loss was more common in the 70--79 years age group than in other age groups (40--49 and 60--69 years) \[[@CR34]\]. These results suggest that height loss progresses rapidly with age in women.

The complication rate of ASD surgery is high \[[@CR35], [@CR36]\], and early care for maintaining sagittal alignment is one of the most important treatments. The use of bisphosphonate and denosumab as an early treatment to maintain spinal alignment and to prevent height loss \[[@CR37], [@CR38]\], especially when combined with the reportedly effective physical treatment for spinal deformity, may result in delaying surgical treatment \[[@CR39], [@CR40]\].

One of the strengths of our study is that height was measured accurately in both times, while in previous reports, participants recalled their previous heights from memory, which might have led to inaccurate height recording \[[@CR11]\]. Our study also had several limitations. Firstly, the number of subjects was low, which affected the findings of our study. However, follow-up periods were longer than previously reported studies. Secondly, our study did not examine QOL score, or living status in relation to height loss. Thirdly, subjects were living in an agriculture area and trunk bending positions were a requirement of their job. Therefore, we cannot generalize our results to other populations. Large longitudinal studies including subjects from more diverse backgrounds are required to address these limitations.

Conclusions {#Sec9}
===========

We observed that height loss was related to ASD and DLS. Height loss was more prominent in women than in men. Height loss is a normal physical change with aging, but excessive height loss is mainly due to the occurrence of spinal kyphosis and scoliosis leading to spinal malalignment. Hence, height loss may be considered as a physical symptom for spinal malalignment.
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